Golden State Medical Supply, Inc., Camarillo, California, has been awarded a maximum $10,306,354 modification (P00001) exercising the first one-year option period of a one-year base contract (SPE2D2-20-D-0098) with four one-year option periods for duloxetine delayed release hydrochloride capsules. This is a fixed-price requirements contract. Locations of performance are California and Spain, with a Sept. 16, 2022, performance completion date. Using customers are Defense Department, Department of Veterans Affairs, Indian Health Services and Federal Bureau of Prisons. Type of appropriation is fiscal 2021 through 2022 defense working capital funds. The contracting agency is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.